New IgG/IgM Antibody Test for COVID-19

Antibody testing for COVID-19 will play a crucial role in the next phase of pandemic management; identifying those who now have immunity.

Join Dr Kara Fitzgerald and Dr Brent Dorval PhD, KBMO Diagnostic’s Chief Scientific Officer, to learn about KBMO’s new COVID-19 Antibody Test. Dr. Dorval previously served as an advisor on the WHO Vaccines and Diagnostics Committee.

In this brief, 20-minute Teach-in webinar we cover:
• Evidence for the use of the immune-capture method to detect COVID-19 IgM and IgG antibodies
• Test accuracy and reliability
• Turnaround time and accessibility of this test kit including KBMOs partnership with a network of 6000 mobile phlebotomists

 

This webinar is brought to you in partnership with Dr Fitzgerald’s online Functional Medicine Clinic Immersion program. Her program, designed to bridge the gap between Functional Medicine theory and practice, offers a window into an active, thriving virtual practice.  Explore our Access Options to learn more. 

  • Click SUBMIT to access the video.

About Brent Dorval, PhD

Dr. Dorval has over 25 years of experience in strategic management of research, manufacturing and regulatory affairs in the area of medical devices and diagnostics. Previously, Dr. Dorval held a number of management positions and served as an advisor to the World Health Organization committee on vaccines and diagnostics. Dr. Dorval is the inventor of the FIT Test which measures IgG and Immune Complexes against a variety of food antigens. In addition, Dr. Dorval has several patents covering rapid assays, novel biomarkers and a novel Polio Virus vaccine. Dr. Dorval holds a Ph.D. in Medical Microbiology and Immunology from the College of Medicine, The Ohio State University and performed postdoctoral studies and was a Visiting Scholar in the Department of Chemistry at the Massachusetts Institute of Technology.